Female Hypoactive Sexual Desire Disorder-Pipeline Insights, 2016 report provides in depth insights on the pipeline drugs and their development activities around the Female Hypoactive Sexual Desire Disorder. The Publisher's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Publisher's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Female Hypoactive Sexual Desire Disorder. Publisher's Report also assesses the Female Hypoactive Sexual Desire Disorder therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.